Welcome to the Cardiogenics Holdings Discussion Forum

Paramagnetic Beads and QL Analyser are Proprietary Products

Free
Message: CardioGenics Announces Commencement of Beta-Site Testing

Game,

Items of note in the Beta Site Testing PR

  1. Only two hospitals affiliated with Wayne State have enrolled patients - does this mean that only two of the numerous affiliated hospitals are participating in the study?
  2. The company "expects beta-site testing to be completed within 10-12 weeks - implies patient enrollment is in line with plan, this is good news.
  3. The company anticipates final clinical testing to commence in Q4 2013 - implies the clinical plan calls for "rolling" the beta-site test into a larger clinical trial that satisfies regulatory agencies requirements for total number of patients evaluated - this is good planning. All CGNH shareholders will benefit if this "rolling" occurs as significant time will be saved in completing the clinical development of the analyzer and troponin 1 cartridge.

As a shareholder of more than 100k shares, I look forward to the Q4 announcement that the beta-site study produced statistically significant results and has been "rolled" into a larger clinical trial. IMO if this scenario unfolds the value of my investment in CGNH will increase significantly.

Ante

Share
New Message
Please login to post a reply